Cancellation of state registration. Timentin

May 29, 2017
Active substances:
Trade names:
ICD-10:
I.A30-A49.A40    Streptococcal septicemia
I.A30-A49.A41    Other septicemia
X.J10-J18.J15    Bacterial pneumonia, not elsewhere classified
X.J20-J22.J20    Acute bronchitis
X.J40-J47.J42    Chronic bronchitis, unspecified
XI.K65-K67.K65.0    Acute peritonitis
XI.K80-K87.K81.0    Acute cholecystitis
XI.K80-K87.K81.1    Chronic cholecystitis
XI.K80-K87.K83.0    Cholangitis
XII.L00-L08.L01    Impetigo
XII.L00-L08.L02    Abscess of skin, boil and carbuncle
XII.L00-L08.L03    Phlegmon
XII.L00-L08.L08.0    Pyoderma
XIII.M00-M03.M00    Pyogenic arthritis
XIII.M86-M90.M86    Osteomyelitis
XIV.N10-N16.N11    Chronic tubulointerstitial nephritis
XIV.N10-N16.N10    Acute tubulointerstitial nephritis
XIV.N10-N16.N15.1    Abscess of kidney and adrenal tissue
XIV.N30-N39.N30    Cystitis
XIV.N30-N39.N34    Urethritis and urethral syndrome
XIV.N40-N51.N41    Inflammatory diseases of the prostate
XIV.N70-N77.N70    Salpingitis and oophoritis
XIV.N70-N77.N71.0    Acute inflammatory disease of the uterus
XIV.N70-N77.N72    Inflammatory disease of the cervix
XIV.N70-N77.N73.0    Acute parametritis and pelvic cellulite
XIX.T79.T79.3    Post-traumatic wound infection, not elsewhere classified
XXI.Z20-Z29.Z29.2    Another type of preventive chemotherapy
Timentin, tIcarcillin + clavulanic acid, broad-spectrum antibiotic, septicemia, intra-abdominal infections, infections in gynecology, urinary tract infections

The Ministry of Health of the Russian Federation, in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On the circulation of medicinal products", decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate P N012635 / 01 dated 07.08.2007 issued by GlaxoSmithKline Trading, Russia):

Timentin (trade name of the drug)

Ticarcillin + Clavulanic acid, 1.5 g + 100 mg, 3 g + 200 mg (international non-patented or batch or chemical name)

lyophilizate for solution for infusion (dosage form, dosage)

SmithKline Beecham Pharmaceuticals, UK Clarendon Road, Worthing, West Sussex, BN 14 8QH, United Kingdom (name and address of the location of the manufacturer of the medicinal product)

on the basis of a filing by an authorized legal entity of ZAO GlaxoSmithKline Trading, an application for the cancellation of the state registration of a medicinal product.